Details of the Drug
General Information of Drug (ID: DMEMBKW)
| Drug Name |
5,8-Dimethoxy-4-methylquinolin-2(1H)-one
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
5,8-Dimethoxy-4-methylquinolin-2(1H)-one; 23947-41-3; 2(1h)-quinolinone, 5,8-dimethoxy-4-methyl-; 5,8-dimethoxy-4-methyl-2-quinolinol; 5,8-dimethoxy-4-methylquinolin-2-ol; ST056710; 5,8-dimethoxy-4-methylhydroquinolin-2-one; 2(1H)-Quinolinone,5,8-dimethoxy-4-methyl-; MZX; NSC109761; casimiroin analogue, 1k; AC1L6LUU; AC1Q6I1R; TimTec1_003888; Oprea1_236890; Oprea1_728115; CHEMBL493174; BDBM29222; CTK4F2623; DTXSID30296530; MolPort-000-699-993; MolPort-002-514-269; BUHDAIGNGIXQJO-UHFFFAOYSA-N; HMS1545A16; ZINC8817671; ALBB-032301
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 219.24 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.2 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


